Therapeutic approaches to chronic obstructive pulmonary disease: An emerging consensus

American Journal of Medicine

Volumn 100, Issue 1 A, 1996, Pages S5-S10

  Chapman, K R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; INFLUENZA VACCINE; IPRATROPIUM BROMIDE; PNEUMOCOCCUS VACCINE; PREDNISONE; THEOPHYLLINE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

ASTHMA; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CORTICOSTEROID THERAPY; EXERCISE; HUMAN; HYPOXEMIA; INHALATIONAL DRUG ADMINISTRATION; MORTALITY; ORAL DRUG ADMINISTRATION; OXYGEN THERAPY; PATIENT EDUCATION; PRIORITY JOURNAL; SMOKING CESSATION; TREMOR; VACCINATION; XEROSTOMIA; KINESIOTHERAPY; REVIEW;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; ASTHMA; BRONCHODILATOR AGENTS; EXERCISE THERAPY; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MUSCARINIC ANTAGONISTS; OXYGEN INHALATION THERAPY; SMOKING CESSATION;

EID: 85013330199     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9343(96)80025-8     Document Type: Conference Paper

References (38)

1. Jackson R. Sears M.R. Beaglehole R. Rea H.H. International trends in asthma mortality: 1970 to 1985 Chest 94 1988 914 918
2. Hargreave F.E. Dolovich J. Newhouse M.T. The assessment and treatment of asthma: a conference report J Allergy Clin Immunol 85 1990 1098 1111
3. International Consensus Report on the Diagnosis and Management of Asthma International Asthma Management Project Clin Exp Allergy 22 Suppl 1 1992 1 72
4. Higgins M. Epidemiology of COPD. State of the art Chest 85 1984 3S 8S
5. (suppl) Manfreda J. Mao Y. Litven W. Morbidity and mortality from chronic obstructive pulmonary disease Am Rev Respir Dis 140 1992 S19 S26
6. Chapman K.R. Bowie D.M. Goldstein R.S. Guidelines for the assessment and management of chronic obstructive pulmonary disease. Canadian Thoracic Society Workshop Group Can Med Assoc J 147 1992 420 428
7. Ferguson G.T. Cherniack R.M. Management of chronic obstructive pulmonary disease N Engl J Med 328 1993 1017 1022
8. Kesten S. Chapman K.R. Physician perceptions and management of COPD Chest 104 1993 254 258
9. Fletcher C. Pete R. The natural history of chronic airflow obstruction Br Med J 1 1977 1645 1648
10. Coultas D.B. The physician's role in smoking cessation Samet J.I.M. Coultas D.B. Clinics in Chest Medicine 1993 W.B. Saunders Philadelphia 755 768
11. Fisher E.B. Jr Lichtenstein E. Haire-Joshu D. Morgan G.D. Rehberg H.R. Methods, successes, and failures of smoking cessation programs Annu Rev Med 44 1993 481 513
12. Tonnesen P. Norregaard J. Simonsen K. Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation N Engl J Med 325 1991 311 315
13. Schneider N.G. Nicotine therapy in smoking cessation. Pharmacokinetic considerations Clin Pharmacokinet 23 1992 169 172
14. Davis A.L. Aranda C.P. Schiffman G. Christianson L.C. Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study Chest 92 1987 204 212
15. Gross N.J. Ipratropium bromide N Engl J Med 319 1988 486 494
16. (suppl) Chapman K.R. The role of anticholinergic bronchodilators in adult asthma and chronic obstructive pulmonary disease Lung 168 1990 295 303
17. Chapman K.R. Anticholinergic bronchodilators for adult obstructive airways disease Am J Med 91 suppl 4A 1991 13S 16S
18. Published erratum appears in Braun S.R. McKenzie W.N. Copeland C. Knight L. Ellersieck M. A comparison of the effect of ipratropium bromide and albuterol in the treatment of chronic obstructive airway disease Arch Intern Med 149 1989 544 547
19. Braun S.R. McKenzie W.N. Copeland C. Knight L. Ellersieck M. Arch Intern Med 150 1990 1242
20. Tashkin D.P. Ashutosh K. Bleecker E.R. Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease. A 90-day multi-center study Am J Med 81 1986 81 90
21. Fakes G.E. Brogden R.N. Heel R.C. Speight T.M. Avery G.S. Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis Drugs 20 1980 237 266
22. 2-agonist Am Rev Respir Dis 132 1985 845 847
23. Wanner A. Effect of ipratropium bromide on airway mucociliary function Am J Med 81 1986 23 27
24. Chapman K.R. Smith D.L. Rebuck A.S. Leenen F.H. Hemodynamic effects of an inhaled beta-2 agonist Clin Pharmacol Ther 35 1984 762 767
25. Gross N.J. Bankwala Z. Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease. Comparison with a beta-adrenergic agent Am Rev Respir Dis 136 1987 1091 1094
26. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986 Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma Am Rev Respir Dis 136 1987 225 244
27. Rebuck A.S. Chapman K.R. Asthma: 2. trends in pharmacologic therapy Can Med Assoc J 136 1987 483 488
28. Newhouse M.T. Is theophylline obsolete? Chest 98 1990 1 3
29. Bleecker E.R. Britt E.J. Acute bronchodilating effects of ipratropium bromide and theophylline in chronic obstructive pulmonary disease Am J Med 91 suppl 4A 1991 24S 27S
30. Guyatt G.H. Townsend M. Pugsley S.O. Bronchodilators in chronic air-flow limitation. Effects on airway function, exercise capacity, and quality of life Am Rev Respir Dis 135 1987 1069 1074
31. Callaghan C.M. Dittus R.S. Katz B.P. Oral corticosteroid therapy for patients with stable chronic obstructive pulmonary disease Ann Intern Med 114 1991 216 223
32. Anthonisen N.R. Long-term oxygen therapy Ann Intern Med 99 1983 519 527
33. Long-term domiciliary oxygen therapy in chronic hypoxic cor pulmonary complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party Lancet i 1981 681 686
34. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group Ann Intern Med 93 1980 391 398
35. Fletcher E.C. Miller J. Divine G.W. Fletcher J.I.G. Miller T. Nocturnal oxyhemoglobin desaturation in patients with COPD with arterial oxygen tensions above 60 mm Hg Chest 92 1987 604 608
36. Guyatt G.H. Townsend M. Kazim F. Newhouse M.T. A controlled trial of ambroxol in chronic bronchitis Chest 92 1987 618 620
37. Current status of alpha-l-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-l-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society Can Med Assoc J 146 1992 841 844
38. Patterson G.A. Maurer J.R. Williams T.J. Cardoso P.G. Scavuzzo M. Todd T.R. Comparison of outcomes of double and single lung transplantation for obstructive lung disease. The Toronto Lung Transplant Group J Thorac Cardiovasc Surg 101 1991 623 631